You just read:

Neuraltus Pharmaceuticals Initiates Confirmatory Phase 2 Study of NP001 in Patients with Amyotrophic Lateral Sclerosis

News provided by

Neuraltus Pharmaceuticals, Inc.

Sep 22, 2016, 08:00 ET